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ORIGINAL ARTICLEAre patients with pulmonary tuberculosis who are identiﬁed through
active case ﬁnding in the community different than those identiﬁed in
healthcare facilities?S. T. Abdurrahman1, L. Lawson2,4, M. Blakiston5, J. Obasanya3, M. A. Yassin5,7, R. M. Anderson4,6, O. Oladimeji2,5, A. Ramsay8 and
L. E. Cuevas5
1) Federal Capital Territory Tuberculosis and Leprosy Control Programme, 2) Zankli Medical Centre, 3) Nigeria Centre for Disease Control, Abuja, 4) Bingham
University, Karu, Nassarawa State, Nigeria, 5) Liverpool School of Tropical Medicine, 6) University of Liverpool, Liverpool, UK, 7) Global Fund to Fight Aids,
Tuberculosis and Malaria and 8) Special Program for Research in Tropical Diseases, WHO/TDR, Geneva, SwitzerlandAbstractThe lack of healthcare access contributes to large numbers of tuberculosis (TB) cases being missed and has led to renewed interest in
outreach approaches to increase detection. It is however unclear whether outreach activities increase case detection or merely identify
patients before they attend health facilities. We compared adults with cough of >2 weeks’ duration recruited in health facilities (1202
participants) or in urban slums (2828 participants) in Nigeria. Participants provided demographic and clinical information and were
screened using smear microscopy. The characteristics of smear-positive and smear-negative individuals were compared stratiﬁed by place
of enrolment. Two hundred nine health facility participants (17.4%) and 485 community-based participants (16.9%) were smear positive
for pulmonary TB. Community-based smear-positive cases were older (mean age, 36.3 vs. 31.8 years), had longer cough duration (10.3
vs. 6.8 weeks) and longer duration of weight loss (4.6 vs. 3.6 weeks) than facility-based cases; and they complained more of fever (87.4%
vs. 74.6%), chest pain (89.0% vs. 67.0%) and anorexia (79.5% vs. 55.5%). Community smear-negative participants were older (mean, 39.4
vs. 34.0 years), were more likely to have symptoms and were more likely to have symptoms of longer duration than smear-negative
facility-based participants. Patients with pulmonary TB identiﬁed in the community had more symptoms and longer duration of illness
than facility-based patients, which appeared to be due to factors differentially affecting access to healthcare. Community-based activities
targeted at urban slum populations may identify a different TB case population than that accessing stationary services.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
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E-mail: Luis.Cuevas@lstmed.ac.ukIntroductionHealth services are often inaccessible to ill individuals in the
community, and this is particularly pertinent to tuberculosis
(TB) in low- and middle-income countries. Despite the scaling
up of TB services, it is widely acknowledged there is still a large© 2016 The Author(s). Published by El
This is an oburden of undiagnosed TB [1], and worldwide, an estimated
one third of the 9.5 million cases occurring each year are
missed by public health services [2]. An important proportion
of these cases are missed because individuals with symptomatic
TB fail to seek medical advice for various reasons. The
nonspeciﬁc presentation of TB, an expectation that symptoms
will improve spontaneously and factors such as widespread
stigma and misunderstanding about TB can delay or prevent
individuals from seeking health services [3,4]. A further signif-
icant barrier to diagnosis is the high transport costs that may
arise from multiple visits required for diagnosis [3,4]. Missed or
delayed TB diagnoses may lead to poorer individual outcomesNew Microbe and New Infect 2017; 15: 35–39
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control measures [5].
Recent years have witnessed renewed interest in the 1978
Alma Ata “Health for All” declaration and the World Health
Organization’s (WHO) call for universal health coverage.
There is thus a need to implement and assess accessible health
service delivery to the community, with several models being
used to improve access to services and enhance the detection
of TB [1,5,6]. With effective community services, TB cases
could be identiﬁed at an earlier stage of disease [5] and larger
numbers of patients may be diagnosed, especially from pop-
ulations underrepresented in stationary health services, such
as women, the elderly and the socioeconomically disadvan-
taged [6]. An increase in detection is likely to be greatest when
high-prevalence populations are targeted, and the WHO thus
recommends systematic screening of high-risk groups with
poor access to healthcare, such as those living in urban slums
[5].
There is, however, debate as to whether active community-
based interventions increase the number of TB cases detected
or whether these cases occurred in patients that would have
attended health services eventually but are instead identiﬁed at
an earlier and less symptomatic stage [5]. The latter assumes
that the population detected by community screening is largely
the same as that which seeks care at health facilities.
Conversely, if TB cases identiﬁed by community screening are
from a population that would have otherwise remained undi-
agnosed [1] or that had an intrinsic delay in presentation as a
result of differences in healthcare access or health-seeking
behaviours [7], then active community screening is likely to
have a greater impact on individual prognosis, transmission and
total case detection. There are, however, limited data
describing whether the proﬁle of TB patients identiﬁed in the
community differs compared to those identiﬁed at health
facilities.
We compared the proﬁle of two large groups in the Federal
Capital Territory (FCT) of Abuja, Nigeria, who were screened
for pulmonary TB (PTB) at health facilities and in the commu-
nity respectively. On the basis of local anecdote, we hypothe-
sized that community-based PTB patients would have a more
prolonged duration of illness and a higher degree of
symptomatology.MethodsThis study took place in the FCT of Nigeria and comprised two
substudies screening adults (18 years old) for PTB on the
basis of cough of more than 2 weeks’ duration or other com-
mon symptoms associated with TB (night sweats, unexplained© 2016 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Micr
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4fever weight loss or haemoptysis). The studies were conducted
between 2010 and 2014. The ﬁrst study was a multicentre
study to evaluate a (then) new scheme called same-day smear
microscopy [8]. The FCT arm of this study was conducted in
the ambulatory clinics of the FCT Tuberculosis and Leprosy
Control Programme (TBLCP) based at ﬁve district hospitals
within Abuja Metropolitan Area Council (AMAC). Patients with
symptoms of TB attend spontaneously or are referred to these
TB clinics from other health centres or outpatient services and
are routinely screened using smear microscopy. In the same-
day scheme, we collected two sputum samples 1 hour apart
on the day of ﬁrst consultation. All adults attending the
participating clinics with cough of more than 2 weeks’ duration
were interviewed by trained nurses and were asked to provide
sputum specimens for examination.
The second group consisted of community-based partici-
pants from a prospective study exploring whether visiting
households of slum settlements surrounding the FCT AMAC to
identify adults with symptoms of PTB would increase TB case
detection. All slums of the remaining ﬁve FCT local government
area councils (Abaji, Bwari, Kuje, Kwali and Gwagwalada) were
listed and were visited in turn over a period of 18 months.
Traditional local leaders were visited to obtain permission to
visit the area. Five teams, each consisting of ﬁve community
health extension workers (CHEWs), one coordinator and a
driver, mapped all the houses partnering with local polio pro-
grammes and visited the slums. CHEWs then went from house
to house to inquire whether there were any residents with
cough of more than 2 weeks’ duration and continued canvasing
the settlement until all households were visited. Once one or
more symptomatic persons in a household was identiﬁed, the
CHEWs collected demographic and clinical information and
obtained two sputum samples 1 hour apart.
Sputum samples in both surveys were transported by study
drivers to Zankli TB Research Laboratory the same day as
collection. This research laboratory is based at Zankli Medical
Centre and is a reference laboratory for the National TBLCP.
Smears were examined using light-emitting diode ﬂuorescence
microscopy and were graded according to WHO criteria [9].
Demographic and clinical data were collected using a similar
structured questionnaire in both surveys. For the purposes of
analysis, the two smears collected on the spot 1 hour apart
were used for analysis to maintain the comparability of the
surveys.
Individuals with positive sputum smears, deﬁned as having at
least one acid-fast bacilli in at least one smear, were considered
to have PTB. All participants identiﬁed with PTB by the surveys
were linked to the nearest treatment centre to initiate appro-
priate therapy. The individuals with negative smears where
considered to be largely free from TB for the purpose ofobiology and Infectious Diseases, NMNI, 15, 35–39
.0/).
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symptoms persisted.
Categorical data were summarized using frequency counts
and percentages, while continuous data were described using
arithmetic means for normally distributed variables (age) and
geometric means for skewed variables (e.g. symptom duration).
Chi-square and t tests were used to assess signiﬁcant differ-
ences between the groups in categorical and continuous vari-
ables respectively. Ethical approval for the ﬁrst study was
obtained from the WHO ethics committee as well as the Liv-
erpool School of Tropical Medicine and FCT research ethics
committees. Approval for the second study was obtained from
the latter two committees. All patients were asked to provide
written informed consent to participate.ResultsA total of 4070 participants with cough of more than 2 weeks’
duration and one or more adequate sputum samples were
included. Of these, 1202 (29.5%) were enrolled at healthcare
facilities and 2868 (70.5%) from the community. The de-
mographic and clinical features of the facility- and community-
based populations are listed in Table 1. As a whole, the popu-
lation screened in the community had a longer duration of
cough (9.9 vs. 4.4 weeks) and a more frequent presence andTABLE 1. Populations screened in community and at
healthcare facilities
Characteristic Community
Healthcare
facility p
Number 2868 1202 —
Age, mean (SD) 39.4 (15.2) 34.0 (10.7) <0.001
Male, n (%) 1447 (51.0) 582 (48.4) 0.142
Marital status, n (%)
Single 610 (21.6) 461 (38.4) <0.001
Married/union 2075 (73.5) 644 (53.6)
Widowed 140 (5.0) 97 (8.1)
HIV status known, n (%) 564 (19.7) 675 (56.2) <0.001
HIV positive, n (%)a 65 (11.5) 482 (71.4) <0.001
Cough duration (weeks), mean (SD) 9.9 (2.9) 4.4 (2.3) <0.001
Fever reported, n (%) 2470 (86.3) 817 (68.0) <0.001
Fever duration (weeks), mean (SD) 3.4 (2.7) 2.1 (2.3) <0.001
Weight loss reported, n (%) 2180 (76.2) 806 (67.1) <0.001
Weight loss duration (weeks), mean
(SD)
4.4 (2.6) 2.5 (2.4) <0.001
Chest pain reported, n (%) 2528 (88.5) 756 (62.9) <0.001
Chest pain duration (weeks), mean
(SD)
3.5 (2.6) 2.1 (2.4) <0.001
Anorexia, n (%) 2087 (73.0) 551 (45.8) <0.001
Anorexia duration (weeks), mean (SD) 3.2 (2.6) 2.0 (2.2) <0.001
Submitted two smears, n (%) 2811 (98.0) 1187 (98.8) 0.133
PTB, n (%)b 485 (16.9) 209 (17.4) 0.746
Variable data were missing for some individuals, so percentages were calculated
using the number of individuals with available response as the denominator.
PTB, positive for pulmonary tuberculosis.
aPercentage positive of those with known HIV status.
bIndividuals who were sputum smear positive for acid-fast bacilli were considered
to have PTB.
© 2016 The Author(s). Published by Elsevier Ltd on behal
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compared to health facility–based participants. Two hundred
nine (17.4%) of those screened at healthcare facilities and 485
(16.9%) of those screened in the community had positive-
sputum-smear PTB.
The demographic and clinical features of the PTB cases are
listed in Table 2. Patients with community-based PTB were
older than patients with health facility–based PTB, were more
likely to be married or in a domestic union and, among the
subgroup who volunteered their HIV status, less likely to have
HIV infection. Patients with community-based PTB also had a
longer duration of cough (10.3 vs. 6.8 weeks) and weight loss
(4.6 vs. 3.6 weeks), and they complained more frequently of
fever, chest pain and anorexia than patients with facility-based
PTB. Patients with health facility–based PTB tended to have
higher-grade smears than patients with community-based
PTB.
The demographic and clinical features of the presumed
largely TB-free participants (negative sputum smear) are lis-
ted in Table 3. They had a similar pattern of demographic and
clinical differences between sites as the patients with PTB.
Within the community-based population, there was no sig-
niﬁcant difference (p >0.05) in symptom duration between
the PTB and TB-free participants. Conversely, within the
facility-based population, PTB patients had a signiﬁcantly
longer (p <0.05) duration of all symptoms and a signiﬁcantlyTABLE 2. Characteristics of PTB cases
Characteristic Community
Healthcare
facility p
Number 485 209 —
Age, mean (SD) 36.3 (13.6) 31.8 (8.6) <0.001
Male, n (%) 322 (66.8) 125 (59.8) 0.093
Marital status, n (%)
Single 141 (29.4) 94 (45.0) <0.001
Married/union 326 (68.1) 99 (47.4)
Widowed 12 (2.5) 16 (7.7)
HIV status known, n (%) 339 (69.9) 127 (60.8) 0.024
HIV positive, n (%)a 39 (11.5) 83 (65.4) <0.001
Cough duration (weeks), mean (SD) 10.3 (2.4) 6.8 (2.6) <0.001
Fever reported, n (%) 424 (87.4) 156 (74.6) <0.001
Fever duration (weeks), mean (SD) 3.4 (2.6) 3.1 (2.5) 0.297
Weight loss reported, n (%) 425 (87.6) 180 (86.1) 0.674
Weight loss duration (weeks), mean
(SD)
4.6 (2.4) 3.6 (2.5) 0.012
Chest pain reported, n (%) 429 (89.0) 140 (67.0) <0.001
Chest pain duration (weeks), mean
(SD)
3.5 (2.6) 3.1 (2.7) 0.292
Anorexia reported, n (%) 385 (79.5) 116 (55.5) <0.001
Anorexia duration (weeks), mean (SD) 3.4 (2.6) 2.9 (2.4) 0.118
Submitted two smears, n (%) 477 (98.4) 209 (100) 0.139
Smear grade, n (%)
Scanty 46 (9.6) 24 (11.5) <0.001
+ 166 (34.6) 33 (15.9)
++ 167 (34.8) 55 (26.4)
+++ 101 (21.0) 96 (46.2)
Variable data were missing for some individuals, so percentages were calculated
using the number of individuals with available response as the denominator.
PTB, positive for pulmonary tuberculosis.
aPercentage positive of those with known HIV status.
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TABLE 3. Characteristics of tuberculosis-free participants
Characteristic Community
Healthcare
facility p
Number 2383 993 —
Age, mean (SD) 40.0 (15.4) 34.5 (11.1) <0.001
Male, n (%) 1125 (47.8) 457 (46.0) 0.375
Marital status, n (%)
Single 469 (20.0) 367 (37.0) <0.001
Married/union 1749 (74.6) 545 (54.9) <0.001
Widowed 128 (5.5) 81 (8.2)
HIV status known, n (%) 225 (9.4) 548 (55.2) <0.001
HIV positive, n (%)a 26 (11.6) 399 (72.8) <0.001
Cough duration (weeks), mean (SD) 9.9 (3.0) 4.0 (2.2) <0.001
Fever reported, n (%) 2046 (86.1) 661 (66.6) <0.001
Fever duration (weeks), mean (SD) 3.4 (2.7) 1.9 (2.2) <0.001
Weight loss reported, n (%) 1755 (73.8) 626 (63.0) <0.001
Weight loss duration (weeks), mean
(SD)
4.4 (2.7) 2.3 (2.3) <0.001
Chest pain reported, n (%) 2099 (88.4) 616 (62.1) <0.001
Chest pain duration (weeks), mean
(SD)
3.5 (2.8) 1.9 (2.2) <0.001
Anorexia reported, n (%) 1702 (71.6) 435 (43.8) <0.001
Anorexia duration (weeks), mean (SD) 3.1 (2.6) 1.8 (2.1) <0.001
Submitted two smears, n (%) 2334 (97.9) 978 (98.5) 0.357
Variable data were missing for some individuals, so percentages were calculated
using the number of individuals with available response as the denominator.
Individuals with negative sputum smears were considered to be largely tuberculosis
free.
aPercentage positive of those with known HIV status.
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participants.DiscussionCommunity-based screening has signiﬁcant potential to in-
crease TB case detection. There is, however, debate on
whether outreach activities are merely identifying individuals
earlier and that these patients would eventually seek healthcare,
which would thus have a limited effect on total case detection;
or if the cases detected in the community represent a different
population that, for many reasons, fail to reach the health
services. To describe the population reached by an outreach
activity in a high-prevalence setting, we compared the charac-
teristics of those screened at stationary healthcare facilities with
those actively screened in urban slums.
In both the health facility and community populations studied,
sputum smear screening of symptomatic individuals identiﬁed a
similar high proportion with PTB, reﬂective of the high preva-
lence of undiagnosed TB in this setting and in line with the
prevalence stated by the national prevalence survey (http://www.
who.int/tb/publications/NigeriaReport_WEB_NEW.pdf). The
population prevalence and consequent detection rate are
important variables when considering the utility of outreach
screening programmes [7]. The community-based population as
a whole was older, had more symptoms and had a longer dura-
tion of symptoms than those screened at healthcare facilities.
Furthermore, the community PTB cases and presumed TB-free
community-based participants had a similar frequency and© 2016 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Micr
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the whole community group were delaying or preventing them
from accessing healthcare. This is not unexpected, as urban slum
populations tend to have limited access to health services.
Because the community population was more symptomatic as a
whole, other comorbidities more common in urban slum pop-
ulations, such as malnutrition, helminth infection or non-TB
bacterial infection, probably contribute to the observed differ-
ences in symptomatology between community and facility-based
participants and may explain the counterintuitive ﬁnding of
community-based PTB cases having lower smear grades than
facility-based cases. There was a higher prevalence of HIV in the
health facility–based patients, which could be partially explained
by patients being directed to TB services by the hospital-based
HIV clinics. The difference in the prevalence of HIV infection
could have contributed to the differences in symptomatology.
PTB cases identiﬁed in the community had a higher frequency
and a longer duration of symptoms than PTB cases identiﬁed at
healthcare facilities. This observation contrasts with some pre-
vious reports that suggested outreach services may identify less
symptomatic cases [10,11] with a shorter duration of symptoms
[12]. This is likely explained by the different approaches used and
the populations assessed. We targeted a high-risk subgroup
(urban slum residents) of the FCT population for outreach ac-
tivities, whereas other studies have used community-wide sur-
veys [10], or had community and facility-based populations that
were sociodemographically homogenous [12], or described
outreach activities in industrialized settings with near-universal
access to healthcare services [11].
The increased and prolonged symptomatology of the PTB
cases identiﬁed in the community population has implications for
the impact of outreach activities. Community-based case ﬁnding
approaches have been shown to increase case detection during
the period of implementation, although it has been postulated that
it may have a limited effect on overall long-term case detection
[13] because, although identiﬁed earlier, these patients may have
eventually sought care as their symptoms progressed [1]. This is a
feasible scenario in areaswhere the community- and facility-based
cases have comparable sociodemographic features and service
access. However, the outreach service in this study identiﬁed
individuals who had been symptomatic for a longer—not
shorter—time, which suggests that these patients may not have
sought care at a more advanced disease stage and that in this
setting community screening may be reaching a different popu-
lation than those attending stationary health services. Therefore,
in this urban slum setting, where individuals likely have socio-
economic constraints on access to healthcare, outreach activities
may increase case detection in both the short and long term.
The secondary nature of the data, which limited the number
of demographic variables, including income and employment,obiology and Infectious Diseases, NMNI, 15, 35–39
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ences identiﬁed between the populations. The unavailability of
higher-sensitivity diagnostics such as sputum culture and the
absence of other markers of disease severity such as chest
radiology also constrained characterization of the populations.ConclusionIn this high-prevalence setting, the populations screened for PTB
in the community and at stationary health facilities had different
clinical characteristics. PTB cases identiﬁed by outreach services
in urban slums were more symptomatic and had a longer
duration of illness than PTB cases identiﬁed at health facilities.
Outreach activities therefore may reach a different population
than stationary services, as differences appear to be due to
factors that differentially affect access in the community popu-
lation at large. This suggests urban slum residents are a popu-
lation where targeted community-based screening activities
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